Infinity Pharmaceuticals | INFI - Current Assets


Infinity Pharmaceuticals reported $19.91M in Current Assets for its fiscal quarter ending in June of 2023.





Current Assets Change Date
AbbVie USD 33.53B 4.47B Mar/2026
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 31.48B 2.42B Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Eisai JPY 761.64B 79.24B Mar/2026
Eli Lilly USD 54.84B 794M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Incyte USD 5.48B 460.36M Mar/2026
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
TG Therapeutics USD 1.09B 456.2M Mar/2026